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Objectives The purpose of this study was to characterize operative outcomes for ascending aorta and arch replacement on
a national scale and to develop risk models for mortality and major morbidity.
Background Contemporary outcomes for ascending aorta and arch replacement in North America are unknown.
Methods We queried the Society of Thoracic Surgeons Database for patients undergoing ascending aorta (with or without
root) with or without arch replacement from 2004 to 2009. The database captured 45,894 cases, including
12,702 root, 22,048 supracoronary ascending alone, 6,786 ascending plus arch, and 4,358 root plus arch.
Baseline characteristics and clinical outcomes were analyzed. A parsimonious multivariable logistic regression
model was constructed to predict risks of mortality and major morbidity.
Results Operative mortality was 3.4% for elective cases and 15.4% for nonelective cases. A risk model for operative
mortality (c-index 0.81) revealed a risk-adjusted odds ratio for death after emergent versus elective operation of
5.9 (95% confidence interval: 5.3 to 6.6). Among elective patients, end-stage renal disease and reoperative sta-
tus were the strongest predictors of mortality (adjusted odds ratios: 4.0 [95% confidence interval: 2.6 to 6.4]
and 2.3 (95% confidence interval: 1.9 to 2.7], respectively; p  0.0001).
Conclusions Current outcomes for ascending aorta and arch replacement in North America are excellent for elective repair; however,
results deteriorate for nonelective status, suggesting that increased screening and/or lowering thresholds for elective inter-
vention could potentially improve outcomes. The predictive models presented may serve clinicians in counseling
patients. (J Am Coll Cardiol 2012;60:1156–62) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.023c
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cDespite the development of improved operative techniques
and circulatory adjuncts, existing published data suggest
that ascending aortic and arch repairs retain significant
morbidity and mortality (1). However, the best clinical
studies suffer important limitations, including single-
institution reporting, small sample sizes, and operative
techniques no longer commonly in use. Thus, the objectives
of this study are: 1) to report the characteristics and
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accepted June 19, 2012.outcomes of patients undergoing ascending aortic and arch
replacement in a large contemporaneous North American
cohort; and 2) to determine the predictors of mortality and
major morbidity for these patients.
Methods
Data source. The Society of Thoracic Surgeons (STS)
Adult Cardiac Surgery Database (ACSD) currently houses
data from 950 participants, representing 90% of the
ardiac surgery centers in the United States. Clinical sites
nter data using uniform definitions. The quality of the data
as been rigorously assessed by comparison with indepen-
ent national and regional datasets (2). The present study
as approved by the Access and Publications Committee of
he STS Workforce for National Databases as well as by the
uke University institutional review board.
atient population. The study population consists of all
atients with aortic pathology requiring repair of the as-
ending aorta (with or without root) with or without arch
eported to the STS ACSD between 2004 and 2009.
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replacement were not included. The STS ACSD first began
distinguishing aortic replacement location (ascending, arch,
descending, and thoracoabdominal) in 2004, with imple-
mentation of case report form version 2.52, and the current
analysis was based on this form.
Data collection and definitions. Those variables previ-
ously identified in the peer-reviewed literature as potential
predictors of outcome in aortic surgery were included as
candidate variables for the analysis, as well as all variables
from existing STS 30-day operative mortality and morbidity
risk models (3). Data regarding maximal aortic diameter,
use of circulatory arrest or adjunctive cerebral perfusion,
connective tissue disorders, and specifics of intraoperative
neuromonitoring were not available for study.
The primary outcome variable was operative mortality,
defined as death from any cause either in-hospital or within
30 days of the index thoracic aortic operation. The second-
ary outcome variable was the composite endpoint of oper-
ative mortality and major morbidity, where major morbidity
was defined using the standard STS database composite of
stroke, renal failure, prolonged ventilation, deep sternal
wound infection, and reoperation. Further details regarding
STS ACSD data definitions are available online.
Statistical analysis. Baseline patient characteristics and
outcomes were summarized by percentage distribution for
categorical variables and by medians and 25th to 75th
percentiles for continuous variables. Missing data were rare
(0.5% for all variables). Missing values of body mass index
were imputed to sex-specific median values. Missing values
of ejection fraction were imputed to sex-specific median
values for patients with congestive heart failure; otherwise,
were imputed to 50%. Missing values of remaining risk
factors and various outcomes were defaulted to their most
common value.
Logistic regression modeling was used to estimate the
risk of the individual outcome as a function of patient
variables. Models were created for the overall study cohort
in addition to the subset of elective patients. Generalized
estimating equations methodology was used to fit the
models (4); and C statistics were calculated and compared
for full and reduced models. For either mortality or major
morbidity and mortality, a reduced model was able to
explain approximately 99% of the variation in the predicted
log odds as estimated by the full model. Full and reduced
models were fit again in the overall population to obtain the
risk adjusted odds ratios (OR) for predictors.
Results
Centers performing proximal aortic replacement. In
2004, the first year the STS ACSD began recording the
location for aortic replacement, 285 North American cen-
ters reported 2,121 proximal (ascending with or without
arch) aortic replacements. By 2008, 806 participating cen-
ters reported 11,033 cases. Figure 1A shows proximal aorticcases captured per year in the
STS ACSD. Figure 1B displays
the proportion of STS ACSD
centers performing proximal aor-
tic replacement and the median
number of cases reported per
center performing the procedure
each year. While the proportion
of centers performing proximal
aortic replacement increased
each year, the number of proxi-
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft surgery
CI  confidence interval
NCSD  National Cardiac
Surgery Database
OR  odds ratio
STS  The Society of
Thoracic Surgeons
Figure 1 Proximal Aortic Replacements Among STS ACSD
Participants by Year
Proximal aortic replacements among The Society of Thoracic Surgeons Adult
Cardiac Surgery Database (STS ACSD) participants by year 2004 to 2009. (A)
Total number of proximal aortic cases captured (blue line) per year by the STS
ACSD and proximal aortic cases as a percentage of total adult cardiac surgery
cases (red line) reported to the ACSD each year. (B) Proportion of ACSD par-
ticipant centers reporting proximal aortic procedures (blue line) and mean num-
ber of cases per reporting center (red line).
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Characteristics
Proximal Aortic Replacement
Overall
(N  45,894)
Root
(n  12,702)
Ascending Alone
(n  22,048)
Ascending  Arch
(n  6,786)
Root  Arch
(n  4,358)
Age, yrs 62 (52–72) 58 (48–69) 64 (54–73) 65 (54–74) 60 (49–70)
Female 32.09 24.85 34.30 39.95 29.78
Race
Caucasian 85.19 87.34 84.85 81.27 86.78
Black 7.61 6.04 7.61 10.86 7.11
Asian 2.00 1.49 2.14 2.58 1.88
Native American 0.15 0.15 0.15 0.15 0.16
Demographic region
Midwest 33.90 35.73 32.20 34.00 37.06
Northeast 20.22 17.62 18.08 26.32 29.07
South 27.10 26.29 30.25 23.90 18.52
West 18.78 20.37 19.46 15.78 15.35
Body mass index, kg/m2 28 (24–31) 28 (25–31) 28 (25–32) 27 (24–31) 27 (24–31)
Hypertension 72.41 66.01 74.74 78.79 69.32
Current or recent smoker 21.10 19.34 21.48 24.42 19.14
Hypercholesterolemia 49.19 47.43 51.10 48.17 46.21
Chronic lung disease 17.77 16.16 18.54 19.16 16.38
Renal function stages
GFR 90 ml/min/1.73 m2 23.30 27.20 21.84 20.76 23.29
GFR 60–89 ml/min/1.73 m2 51.81 52.50 51.76 48.84 54.64
GFR 30–59 ml/min/1.73 m2 22.04 17.98 23.34 26.92 19.69
GFR 29 ml/min/1.73 m2 1.65 1.32 1.79 2.08 1.24
Dialysis 1.20 0.99 1.27 1.40 1.15
Immunosuppressive treatment 2.77 2.31 2.70 3.51 3.33
Diabetes mellitus 12.00 10.00 13.00 11.00 9.00
Peripheral vascular disease 19.36 16.74 19.34 23.74 20.24
Cerebrovascular disease 11.28 8.88 11.74 14.44 11.06
History of myocardial infarction 11.43 9.23 13.35 11.11 8.65
History of congestive heart failure 20.01 22.40 19.58 15.38 22.44
Any previous cardiovascular surgery 16.69 16.11 15.67 19.19 19.62
Previous CABG 5.38 3.92 6.30 5.78 4.31
Previous valve procedure 10.28 10.97 9.36 10.36 12.76
Pre-operative cardiogenic shock 3.91 2.50 4.21 5.94 3.30
Procedure status
Elective 59.22 70.11 55.53 47.27 64.80
Urgent 20.46 19.03 21.69 20.07 18.95
Emergent 19.19 10.16 21.55 30.78 15.53
Salvage 1.08 0.66 1.17 1.83 0.71
Urgent reason
Anatomy 29.52 23.71 33.43 30.54 22.15
Aortic dissection 24.74 14.36 22.56 47.36 30.51
Valve dysfunction 23.53 38.68 20.13 8.00 24.46
Congestive heart failure 11.44 15.60 10.01 5.73 16.95
Emergent reason
Aortic dissection 93.87 89.54 93.92 96.17 94.68
Shock 2.1 2.8 2.0 1.5 2.5
Valve dysfunction 1.39 4.65 0.86 0.53 1.48
Concomitant CABG 25.94 24.50 28.83 21.19 22.85
Concomitant mitral valve procedure 7.2 5.0 9.4 6.3 4.8
Concomitant arrhythmia correction 4.97 5.53 5.45 3.04 3.85
Operation time, h 5.2 (4.1–6.6) 5.2 (4.2–6.7) 4.8 (3.7–6.1) 5.7 (4.6–7.1) 6.2 (4.9–7.7)
Cross-clamp time, min 111 (79–152) 131 (101–170) 95 (67–129) 102 (70–141) 154 (118–197)Values are median (25th to 75th percentiles) or %.
CABG  coronary artery bypass graft surgery; GFR  glomerular filtration rate.
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constant at approximately 12 cases per center.
Patient and operative characteristics. Table 1 displays
atient demographics for the overall cohort stratified by
ocation of aortic replacement. As a whole, patients under-
oing supracoronary ascending aortic replacement with or
ithout arch were older and had more comorbid conditions.
verall, 59% of cases were elective, 20% urgent, and 20%
mergent. For emergent cases, aortic dissection was the
ndication 94% of the time. Supracoronary ascending with
r without arch procedures were most common in the
onelective setting, with 50% of ascending plus arch cases
eing nonelective. The addition of arch replacement to
scending aortic or root replacement increased cross-clamp
ime and operative time modestly.
linical outcomes. Figure 2 displays operative mortality
tratified by case status. Table 2 shows univariate outcomes
or the overall proximal aortic population, stratified by
ocation of aortic repair and elective versus nonelective case
tatus. Overall operative mortality was 8.3%, including 3.4%
or elective and 15.4% for nonelective cases. Mortality was
ighest for nonelective supracoronary ascending plus arch
eplacement, at 17.6%.
Nonfatal adverse outcomes included stroke or coma in
.6% of patients, renal failure in 8.3%, perioperative myo-
ardial infarction in 2.4%, and prolonged ventilation in
7.8%. Similar to mortality, stroke rate was highest for cases
nvolving replacement of the supracoronary ascending aorta
nd arch (Table 2). Adverse outcomes were more common
fter nonelective operation, with the exception of perioper-
tive myocardial infarction which occurred with similar
requency after elective and nonelective operation.
redictive models. Table 3 displays predictors in the
educed model for operative mortality after proximal aortic
eplacement (c-index 0.82). The risk-adjusted OR for death
fter emergent versus elective operation was 5.9 (95%
Figure 2 Operative Mortality
Operative mortality, defined as death from any cause either in-hospital or within
30 days of the index thoracic aortic operation, categorized by procedure
status.Sconfidence interval [CI]: 5.3 to 6.6; p  0.0001]. Concom-
itant coronary artery bypass graft surgery (CABG [adjusted
OR: 2.1]) or mitral valve procedure (adjusted OR: 1.6) each
conferred significantly higher risk of death. Adjusted OR
for mortality with arch involvement was 1.2 (95% CI: 1.1
to 1.4; p  0.0002). However, the adjusted OR for root
involvement was 1.0 (95% CI: 0.9 to 1.1; p  0.72) in the
full model and did not remain in the reduced model.
Table 4 displays results of the multivariable model for
major morbidity or mortality (c-index 0.78), with results
of the predictive model being similar to the operative
mortality model.
Table 5 displays predictors of operative mortality among
patients undergoing elective operation (c-index 0.77).
Among elective patients, end-stage renal disease (pre-
operative dialysis) was the strongest predictor of mortality,
with adjusted OR 4.0 (95% CI: 2.6, 6.4; p  0.0001). For
patients undergoing reoperation (any redo sternotomy),
adjusted OR for mortality was 2.3 (95% CI: 1.9 to 2.7; p 
.0001). Predictors of major morbidity and mortality among
lective patients are presented in Table 6 (c-index 0.71),
ith results of the predictive model again similar to those of
he operative mortality model.
iscussion
he present study provides a broad overview of the current
ractice and outcomes for proximal aortic replacement in
orth America. The 45,894 patients captured in the STS
CSD between 2004 and 2009 represent the largest con-
emporaneous cohort of proximal aortic replacement re-
orted to date. The elective mortality of 3.4% is excellent;
owever, results markedly deteriorate for nonelective status,
nd the overall operative mortality of 8.3% and stroke rate of
.6% indicate room for continued improvement. The mul-
ivariable models predicting mortality and major morbidity
onfirm the critical prognostic importance of procedure
tatus: adjusted OR 5.9 and 2.0, respectively, for operative
eath with emergent and urgent operation, versus elective
ases. Arch involvement was associated with increased risk
f mortality and major morbidity; however, root involve-
ent was not. Adverse outcomes appeared more common
fter supracoronary ascending (with or without arch) re-
lacement, despite being technically less challenging than
oot replacement, in both elective and nonelective settings,
ikely secondary to the older age and greater comorbidities
f these patients. Among the subset of elective patients,
evere renal dysfunction, reoperation status, severe lung
isease, and concomitant procedures are the strongest pre-
ictors of operative mortality and major morbidity.
While the morbidity and mortality associated with tho-
acic aortic repair remain high relative to other surgical
rocedures, patient outcomes have improved in each of the
ast 3 decades due in part to advances in operative ap-
roaches, perioperative care, and increased surveillance (4–6).
ingle-institution studies from aortic surgery referral centers
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30-day mortality from 5% to 10%, stroke from 3% to 6%,
and renal failure from 2% to 10% (7–9). The findings of the
present study indicate comparable results among STS
ACSD participating centers.
Although an increasing number of proximal aortic re-
placement cases were reported to the STS ACSD during
each year of study, the median number of cases per
participant doing at least 1 case has risen only slightly, with
the 2008 average being only 12 cases per participating
center. A recent study analyzing the effects of institutional
volumes on operative outcomes for aortic root replacement
in North America using the STS ACSD found a clear,
inverse association between hospital procedure volume and
post-operative mortality, which appeared most pronounced
Unadjusted Event RatesTable 2 Unadjusted Event Rates
Outcome
Overall
(N  45,894)
Roo
(n  12
Operative mortality,
in-hospital or 30-day
8.28 6.0
Elective 3.36 2.7
Nonelective 15.42 13.7
Stroke 72 h or coma 24 h 6.62 3.9
Elective 3.17 2.2
Nonelective 9.84 6.9
Renal failure 8.31 6.2
Elective 4.41 3.9
Nonelective 14.00 11.8
Dialysis 3.86 2.8
Elective 1.68 1.3
Nonelective 7.02 6.2
Perioperative MI 2.39 1.9
Elective 2.48 2.4
Nonelective 2.26 2.6
Pneumonia 6.65 4.4
Elective 4.12 3.0
Nonelective 10.34 7.8
Deep sternal wound infection 0.58 0.6
Elective 0.45 0.3
Nonelective 0.76 0.7
Reoperation for bleeding 7.39 7.1
Elective 5.68 5.7
Nonelective 9.88 10.5
Any reoperation 14.22 12.7
Elective 10.09 9.5
Nonelective 20.24 20.1
Prolonged ventilation 24 h 27.81 20.2
Elective 16.23 12.7
Nonelective 44.66 37.6
Post-operative length of stay
14 days
15.73 16.1
Elective 9.31 7.0
Nonelective 25.08 21.0
Values are %.
MI  myocardial infarction.among centers performing fewer than 30 to 40 electiveaortic root procedures per year (10). Recent data from 2,218
CABG patients, however, has found that outcomes did not
vary significantly based on volume but instead were corre-
lated with compliance with National Quality Forum process
measures (11). This finding suggests an opportunity for
further systems analysis aimed at optimizing quality of care
for patients requiring proximal aortic replacement by exam-
ining the role of volume and other processes of care in
thoracic aortic surgery.
The risk models presented herein may assist clinicians in
risk stratification and patient counseling when planning
proximal aortic replacement. Urgent/emergent procedure
status, reoperation, chronic renal failure, and pulmonary
disease have each been associated with adverse outcomes in
smaller observational studies of ascending and aortic arch
oximal Aortic Replacement
Ascending Alone
(n  22,048)
Ascending  Arch
(n  6,786)
Root  Arch
(n  4,358)
8.67 11.67 7.62
3.41 5.05 3.29
15.25 17.62 15.58
6.88 11.03 6.29
3.24 5.33 3.36
9.83 13.09 9.58
8.45 11.54 8.56
4.22 6.07 4.96
13.75 16.45 15.19
3.81 5.92 3.88
1.57 2.83 1.91
6.63 8.70 7.50
2.53 3.27 2.80
2.01 3.89 2.94
1.90 2.71 2.54
6.82 9.80 7.25
4.06 6.45 5.10
10.26 12.81 11.21
0.48 0.75 0.48
0.52 0.59 0.28
0.69 0.90 0.85
7.16 8.27 7.89
5.34 6.23 6.41
9.44 10.10 10.63
13.81 17.89 14.96
9.47 12.71 11.44
19.23 22.55 21.45
27.99 40.44 29.39
15.49 25.97 19.23
43.63 53.43 48.11
11.23 22.90 15.72
9.28 14.82 10.27
24.68 30.15 25.75Pr
t
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7repair (1,8,9) and are corroborated by the results of the
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mitral valve procedure was shown to increase risk for
mortality and major morbidity among the overall study
cohort (Tables 3 and 4) as well as the subset of elective
atients (Tables 5 and 6). In addition, concomitant arch
replacement was associated with an increased risk for
adverse outcomes in all models, but root replacement was
not. For the clinician counseling patients before an elective
proximal aortic replacement procedure, the predictive mod-
els based on data for 27,000 elective patients provide a
guide to estimating the increased risk of perioperative death
and major morbidity in the setting of renal disease, lung
disease, heart failure, and other comorbidities.
The current STS ACSD study presents a first look at
outcomes for repair of acute type A aortic dissection in North
America, with 94% of the 9,289 emergent cases due to acute
aortic dissection. Mortality in this cohort was 21.5%, which is
very similar to the approximately 25% 30-day mortality for
patients treated surgically in reports from the International
Registry of Acute Aortic Dissection (12). The current cohort
represents the largest report of emergent type A dissection
repairs to date and, unfortunately, highlights that results with
Selected Predictors ofOperative Mortality Among All PatientsTable 3 Selected Predictors ofOperative Mortality Among All Patients
Variable
Adjusted OR
(95% CI) p Value
Status: emergent vs. elective 5.91 (5.31–6.58) 0.0001
Pre-operative shock 2.01 (1.74–2.31) 0.0001
Status: urgent vs. elective 2.01 (1.78–2.27) 0.0001
Concomitant CABG 2.14 (1.87–2.46) 0.0001
Concomitant mitral valve procedure 1.63 (1.36–1.96) 0.0001
Any reoperation 1.63 (1.43–1.86) 0.0001
Cerebrovascular disease 1.43 (1.28–1.59) 0.0001
Chronic kidney disease stage 3 or
greater, GFR 60 ml/min/1.73 m2
1.43 (1.32–1.56) 0.0001
Moderate or severe chronic lung disease 1.36 (1.20–1.54) 0.0001
Arch involvement 1.23 (1.10–1.37) 0.0002
CI  confidence interval; OR  odds ratio; other abbreviations as in Table 1.
Selected Predictors of MajorMorbidity an M tality Among All PatientsTable 4 Selected Predictors of MajorMorbidity and Mortality Among All Patients
Variable
Adjusted OR
(95% CI) p Value
Status: emergent vs. elective 6.72 (6.25–7.22) 0.0001
Pre-operative shock 2.00 (1.71–2.34) 0.0001
Status: urgent vs. elective 1.81 (1.69–1.93) 0.0001
Myocardial infarction within 6 h 1.78 (1.26–2.51) 0.0011
Severe chronic lung disease 1.72 (1.48–1.99) 0.0001
Any reoperation 1.62 (1.48–1.78) 0.0001
Concomitant CABG 1.59 (1.47–1.72) 0.0001
Chronic kidney disease stage 3 or
greater, GFR 60 ml/min/1.73 m2
1.55 (1.45–1.66) 0.0001
Concomitant mitral valve procedure 1.54 (1.36–1.73) 0.0001
Arch involvement 1.45 (1.31–1.62) 0.0001
Cerebrovascular disease 1.37 (1.27–1.47) 0.0001Abbreviations as in Tables 1 and 3.surgical treatment of this disease appear to have improved little
over the past 20 years (13).
The most common indication for replacement of the
ascending aorta and/or arch is thoracic aortic aneurysm
(8,13). Current American College of Cardiology/American
Heart Association/American Association for Thoracic Sur-
gery/STS guidelines recommend evaluation for elective repair
in asymptomatic patients with an ascending (Class I recom-
mendation) or arch (Class IIa) diameter of 5.5 cm and prompt
evaluation for surgical intervention in patients with symptom-
atic aneurysms (Class I) (14). These current joint U.S. society
guideline size criteria recommendations are based on previous
observations that the risk of a serious adverse event (rupture,
dissection, death) exceeds the risk of elective operation when
the maximum aortic diameter exceeds 5.5 to 6.0 cm. This
recommendation is contingent upon the assumption that the
risk of operation is approximately 5% (16). We show herein
that the current elective operative mortality is actually only
3.5% across the U.S. and Canada, suggesting that current
diameter thresholds may need to be reconsidered.
To this point, in a 2007 report from the International
Registry of Acute Aortic Dissection, nearly 60% of acute
type A dissection patients had ascending aortic diameters
5.5 cm at the time of dissection, and approximately 40%
Selected Predictors ofOperative Mortality Among Elective PatientsTable 5 Selected Predictors ofOperative Mortality Among Elective Patients
Variable
Adjusted OR
(95% CI) p Value
Pre-operative dialysis 4.04 (2.56–6.37) 0.0001
Any reoperation 2.29 (1.93–2.70) 0.0001
Concomitant CABG 1.99 (1.70–2.32) 0.0001
Moderate or severe chronic lung disease 1.85 (1.52–2.25) 0.0001
Congestive heart failure, NYHA class IV 1.74 (1.28–2.38) 0.0005
Concomitant mitral valve procedure 1.69 (1.34–2.14) 0.0001
Female vs. male 1.57 (1.36–1.83) 0.0001
Immunosuppressive treatment 1.55 (1.10–2.17) 0.0113
Age 70 yrs, 5-yr increments 1.44 (1.33–1.56) 0.0001
Pre-operative atrial fibrillation 1.32 (1.12–1.56) 0.0011
NYHA  New York Heart Association; other abbreviations as in Tables 1 and 3.
Selected Predictors of MajorMorbidity an M tality for Elective PatientsTable 6 Selected Predictors of M jorMorbidity and Mortality for Elective Patients
Variable
Adjusted OR
(95% CI) p Value
Chronic kidney disease stage 4 or
greater, GFR 30 ml/min/1.73 m2
2.68 (2.18–3.30) 0.0001
Severe chronic lung disease 2.05 (1.71–2.47) 0.0001
Any reoperation 1.88 (1.71–2.07) 0.0001
Concomitant mitral valve procedure 1.75 (1.52–2.01) 0.0001
Congestive heart failure, NYHA class IV 1.57 (1.25–1.97) 0.0001
Concomitant CABG 1.55 (1.44–1.67) 0.0001
Aortic arch aneurysm 1.50 (1.31–1.72) 0.0001
Race: black vs. white 1.50 (1.29–1.74) 0.0001
History of myocardial infarction 1.32 (1.14–1.54) 0.0001
Age 70 yrs, 5-yr increments 1.31 (1.24–1.39) 0.0001Abbreviations as in Tables 1, 3, and 5.
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result in emergent operations, the mortality for those cases,
on the basis of the present report, is 21.5%. With an overall
elective mortality of only 3.5% for proximal aortic replace-
ment (adjusted OR: 5.9 for operative mortality with emer-
gent vs. elective cases), the question arises as to whether we
are waiting too long to intervene. Given the large denom-
inator of patients with ascending aortic diameters between 4
cm and 5 cm, however, it is likely not feasible to simply
recommend lowering diameter thresholds as a means of
improving overall outcomes by diminishing the number of
urgent/emergent procedures (18). Rather, a more practical
approach would be increased screening and improved med-
ical therapy for patients at risk for aortic aneurysm and/or
dissection (6). Continual broadening of clinical awareness of
thoracic aneurysms and dissections and the methods of
diagnosis should be expected to reduce the need for urgent
or emergent operation and thereby reduce associated pro-
cedural morbidity and mortality.
Study limitations. The clinical registry studied was obser-
vational, and the results of the analyses represent hypothesis
generation. Although the data source represents a signifi-
cant majority of U.S. cardiac surgical centers and includes
the most recent reported results, data were limited to those
reported through the STS ACSD and did not reliably
distinguish underlying aortic pathology necessitating prox-
imal aortic replacement.
Further, details of the specific operative procedure per-
formed, for example, proximal arch versus total arch, are
limited in the data analyzed. However, given the only
modest increase in operative and aortic cross-clamp times
observed in cases in which concomitant arch replacement
was performed (Table 1), we would predict that the majority
of arch procedures reported herein represent proximal or
hemiarch replacement. Data were also lacking regarding details
of potentially important variations in aortic replacement tech-
nique including aortic diameter, connective tissue disorder
diagnosis, degree of hypothermia, cerebral perfusion, and use
of neurologic monitoring. Finally, all STS ACSD outcomes
data are voluntarily self-reported without external adjudication
of adverse events or universal auditing, which opens the
possibility of under-reporting event rates.
Conclusions
Proximal aortic replacement is increasingly being performed
in North America. Current outcomes for ascending aorta and
arch replacement are excellent for elective repair; however,
results are much less favorable for patients requiring nonelec-
tive procedures. This finding suggests increased screening of
at-risk populations as well as lowering aortic diameter thresh-
olds triggering elective intervention could potentially improve
outcomes by reducing the fraction of operative procedures
performed in nonelective circumstances. The predictive models
presented may serve clinicians in developing risk stratification
strategies when they counsel patients.Reprint requests and correspondence: Dr. G. Chad Hughes,
Director Aortic Surgery Program, Division of Thoracic and
Cardiovascular Surgery, Department of Surgery, Box 3051, Duke
University Medical Center, Durham, North Carolina 27710. E-mail:
gchad.hughes@duke.edu.
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